\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Stock Quote

NASDAQCRDF
$11.06
NASDAQCRDF
Open
$10.80
Change
$0.35 (3.27%)
Day's Range
$10.29 - $11.60
52-Week Range
$0.71 - $12.30
Volume
384.8K
Market Cap
$276.5M